These compounds have some common targets but have also been demonstrated to have distinct biological effects on breast cancer cells [13,14] and the relatively high concentrations necessary to inhibit the expression of CDK6 and to induce cell cycle arrest in breast cancer (from 50 to 200 μM) [15,16]. The gene discussed is CDK6; the disease is breast carcinoma.